References
- Strom T B, Loertscher R. Cyclosporine-induced nephrotoxicity. N Engl J Med 1984; 311: 728–729
- Bia M J, Tyler KA. Effect of cyclosporine on renal ischemic injury. Transplantation 1987; 43(6)800–804
- Humes H D, Jackson N M, O'Connor R P, Hunt D A, White MD. Pathogenetic mechanisms of nephrotoxicity: insight into cyclosporin nephrotoxicity. Transplant Proc 1985; 17: 51–62
- Schrier R W, Arnold P E, Van Putten V J, Burke TJ. Cellular calcium in ischemic acute renal failure: role of calcium entry blockers. Kidney Int 1987; 32: 313–321
- Grekas D M, Kalekou H N, Christodoulou S, Tourkantonis A. Effect on nifedipine in the protection of renal function during in situ preservation. Nephrol Dial Transplant 1987; 2: 179–182
- Burke T J, Arnold P E, Gordon J A, Bulger R E, Dobyan D C, Schrier RW. Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. Functional morphological and mitochondrial studies. J Clin Invest 1984; 74: 1830–1840
- Myers BD. Cyclosporine nephrotoxicity. Kidney Int 1986; 30: 964–974
- Murray B M, Paller M S, Ferris TF. Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int 1985; 28: 767–774
- Moran M, Tomlanovich S, Myers BD. Cyclosporine-induced chronic nephropathy in human recipients of cardiac allografts. Transplant Proc 1985; 17: 185–190, Suppl I
- Myers B D, Ross J, Newton L, Leutscher J, Perloth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699–705
- The Canadian Multicentre Transplant Study Group: A randomized clinical trial of cyclosporine in cadaveric renal transplantation: analysis at three years. N Engl J Med 1986; 314: 1219–1225
- La Castro, Hillebrand G, W Land, Schneider B, K Gunther, Gurland HJ. Cyclosporine in patients with oligoanuria after cadaveric kidney transplantation. Transplant Proc 1983; 15(4)2699–2701, Suppl l
- Kanzai G, Stowe N, Steinmuller D, Ho-Hsieh H, Novick A. Effect of cyclosporine upon the function of ischemically damaged kidneys in the rat. Transplantation 1986; 41: 782–787
- Siegel H, Ryffel B, Petric P, Shoemaker D P, Mihatsch M. Cyclosporine the angiotensin-aldosterone system and renal adverse reactions. Transplant Proc 1983; 15: 2719–2725
- Perico N, Benigna A, Zoja C, Delaini F, Remuzzi G. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin-A. Am J Physiol 1986; 251: F581–584
- Provoost AP. Cyclosporine nephrotoxicity in rats with an acute reduction in renal function. Am J Kidney Dis 1986; 8(5)314–318
- Loutzenhiser R, Epstein M. Effect of calcium antagonists on renal hemodynamics. Am J Physiol 1985; 249: F619–629
- Cauvin C, Loutzenhiser R, Van Breemen C. Mechanisms of calcium antagonist induced vasodilatation. Annu Rev Pharmacol 1983; 23: 373–396
- Bell A J, Lindner A. Effects of verapamil and nifedipine on renal function and hemodynamics in the dog. Renal Physiol 1984; 7: 329–336
- Gg Krishna, Narins RG. Calcium channel blockers: progression of renal disease. Circulation 1989; 80(6)IV47–51
- Marre M, Misumi J, De Raemsch K, Corvol P, Menarol J. Diuretic and natriuretic effect of nifedipine on isolated perfused rat kidney. J Pharmacol Exp Ther 1982; 23: 263–270
- Cheung J Y, Leaf A, Bonventre JV. Mechanism of protection by verapamil and nifedipine from anoxic injury in isolated cardiac myocytes. Am J Physiol 1984; 246: C323–329
- Kahan BD. Cyclosporine nephrotoxicity: Pathogenesis, prophylaxis, therapy, and prognosis. Am J Kidney Dis 1986; 8(5)323–331